Bio Innovation Conference | Christopher McDonald
page-template-default,page,page-id-17804,page-child,parent-pageid-16863,ajax_fade,page_not_loaded,,qode-child-theme-ver-1.0.0,qode-theme-ver-17.2,qode-theme-bridge,qode_header_in_grid,wpb-js-composer js-comp-ver-5.6,vc_responsive

Christopher McDonald

Christopher McDonald

Vice President of Manufacturing, Kite Pharma

Chris McDonald is Vice President of Manufacturing for Kite Pharma where he is responsible for design, construction, start-up and licensure of a greenfield cell therapy manufacturing facility.  Chris was the first employee hired for the Frederick, MD facility with plans to grow the site to 300+ staff over the coming years.  Prior to joining Kite, Chris was the General Manager for the Fredrick, MD AstraZeneca Biologics manufacturing site as well as the General Manager for AZ’s Colorado operations.

Prior to AstraZeneca, Chris spent ten years working for Novartis Vaccines. Preceding Novartis, Chris spent 10 years with Amgen and 7 years with Matrix Technologies, an independently owned automation company based in Maumee, OH. In all three companies, Chris held numerous positions of increasing responsibility.

Chris holds a bachelor’s in Computer Science from Eastern Michigan University and an MBA from Duke’s Fuqua School of Business where he was a Fuqua Scholar (top 10% of his class).